Cargando…

Association between PD-1 and PD-L1 Polymorphisms and the Risk of Cancer: A Meta-Analysis of Case-Control Studies

A number of case-control studies regarding the association of the polymorphisms in the programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) genes with the risk of cancer have yielded inconsistent findings. Therefore, we have conducted a comprehensive, updated meta-analysis study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hashemi, Mohammad, Karami, Shima, Sarabandi, Sahel, Moazeni-Roodi, Abdolkarim, Małecki, Andrzej, Ghavami, Saeid, Wiechec, Emilia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721817/ https://www.ncbi.nlm.nih.gov/pubmed/31405171 http://dx.doi.org/10.3390/cancers11081150

Ejemplares similares

An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer
por: Moazeni-Roodi, Abdolkarim, et al.
Publicado: (2020)

LMO1 polymorphisms and the risk of neuroblastoma: Assessment of meta‐analysis of case‐control studies
por: Hashemi, Mohammad, et al.
Publicado: (2019)

Investigation of ATG16L1 rs2241880 Polymorphism with Cancer Risk: A Meta-Analysis
por: Moazeni-Roodi, Abdolkarim, et al.
Publicado: (2019)

Evaluating the Possible Association between PD-1 (Rs11568821, Rs2227981, Rs2227982) and PD-L1 (Rs4143815, Rs2890658) Polymorphisms and Susceptibility to Breast Cancer in a Sample of Southeast Iranian Women
por: Karami, Shima, et al.
Publicado: (2020)

The 40bp indel polymorphism of MDM2 increase the risk of cancer: An updated meta-analysis
por: Moazeni-Roodi, Abdolkarim, et al.
Publicado: (2019)

Association between IL-27 Gene Polymorphisms and Cancer Susceptibility in Asian Population: A Meta-Analysis
por: Moazeni-Roodi, Abdolkarim, et al.
Publicado: (2020)

Association between rs1862513 and rs3745367 Genetic Polymorphisms of Resistin and Risk of Cancer: A Meta-Analysis
por: Hashemi, Mohammad, et al.
Publicado: (2018)

Association between miR-124-1 rs531564 polymorphism and risk of cancer: An updated meta-analysis of case-control studies
por: Moazeni-Roodi, Abdolkarim, et al.
Publicado: (2018)

Association between Genetic Polymorphisms of miR-1307, miR-1269, miR-3117 and Breast Cancer Risk in a Sample of South East Iranian Women
por: Sarabandi, Sahel, et al.
Publicado: (2021)

Association between P2X7 Polymorphisms and Susceptibility to Tuberculosis: An Updated Meta-Analysis of Case-Control Studies
por: Taheri, Mohsen, et al.
Publicado: (2019)

Evaluation of Paraoxonase Activity in Children With Nephrotic Syndrome
por: Hashemi, Mohammad, et al.
Publicado: (2013)

Association between toll-like receptor2 Arg677Trp and 597T/C gene polymorphisms and pulmonary tuberculosis in Zahedan, Southeast Iran
por: Naderi, Mohammad, et al.
Publicado: (2013)

Association of PDCD6 polymorphisms with the risk of cancer: Evidence from a meta-analysis
por: Hashemi, Mohammad, et al.
Publicado: (2018)

Correction: Association of PDCD6 polymorphisms with the risk of cancer: Evidence from a meta-analysis
por: Hashemi, Mohammad, et al.
Publicado: (2020)

LAPTM4B gene polymorphism augments the risk of cancer: Evidence from an updated meta‐analysis
por: Hashemi, Mohammad, et al.
Publicado: (2018)

Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
por: Shen, Xian, et al.
Publicado: (2018)

Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
por: Bai, Jie, et al.
Publicado: (2017)

Tumor Suppression by PD-1/PD-L1 Interaction Blockage in Mice Model
por: Salehi, Shima, et al.
Publicado: (2023)

Basis of PD1/PD-L1 Therapies
por: Seliger, Barbara
Publicado: (2019)

Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
por: De Sousa Linhares, Annika, et al.
Publicado: (2019)

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
por: Diggs, Laurence P., et al.
Publicado: (2017)

Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis
por: Elias, Rawad, et al.
Publicado: (2018)

Effectiveness of anti-PD-1/PD-L1 antibodies in urothelial carcinoma patients with different PD-L1 expression levels: a meta-analysis
por: Liu, Junqi, et al.
Publicado: (2018)

PD-1/PD-L1 Inhibitors in Cervical Cancer
por: Liu, Yuncong, et al.
Publicado: (2019)

PD-L1/PD-1 Axis in Glioblastoma Multiforme
por: Litak, Jakub, et al.
Publicado: (2019)

A snapshot of the PD-1/PD-L1 pathway
por: Ghosh, Chinmoy, et al.
Publicado: (2021)

The PD-1:PD-L1 axis in Inflammatory Arthritis
por: Canavan, Mary, et al.
Publicado: (2021)

An update on immunotherapy with PD-1 and PD-L1 blockade
por: Koh, Sung Ae
Publicado: (2021)

PD-1/PD-L1 axis in organ fibrosis
por: Zhao, Youliang, et al.
Publicado: (2023)

Progress of research on PD-1/PD-L1 in leukemia
por: Cao, Huizhen, et al.
Publicado: (2023)

PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy
por: Bocanegra, Ana, et al.
Publicado: (2020)

Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
por: Niu, Mengke, et al.
Publicado: (2022)

From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades
por: Zhao, Xuan, et al.
Publicado: (2022)

PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance
por: Huang, Changsheng, et al.
Publicado: (2023)

High‐affinity PD‐1 molecules deliver improved interaction with PD‐L1 and PD‐L2
por: Li, Yanyan, et al.
Publicado: (2018)

Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis
por: Guo, Xiaodi, et al.
Publicado: (2020)

Predictive and Prognostic Role of PD-L1 in Urothelial Carcinoma Patients with Anti-PD-1/PD-L1 Therapy: A Systematic Review and Meta-Analysis
por: Liu, Haoran, et al.
Publicado: (2020)

Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
por: Long, Yiru, et al.
Publicado: (2022)

Relationship of PD-1 (PDCD1) and PD-L1 (CD274) Single Nucleotide Polymorphisms with Polycystic Ovary Syndrome
por: Han, Rui, et al.
Publicado: (2021)

The Relationship Between PD-1(rs2227981) and PD-L1(rs2890658) Polymorphisms and Urothelial Cell Carcinoma
por: Hlaing, Sa Tin Myo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ifo74spbpboki3ohiojpqgq5th